Published: 2019-04-29

Laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a single centre experience

Shah Touseef Arajmand, Yaqoob Hassan, Mela Ram Attri, Nida Shafiq


Background: Laparoscopic Nissen fundoplication is currently the surgical treatment of choice for gastro-esophageal reflux disease (GERD) in properly selected patients.

Methods: Laparoscopic Nissen fundoplication was performed in 36 patients of GERD, Government Medical College over a period of 2 years. Pre-operative evaluation included baseline investigations and clinical assessment by using GERD Questionnaire and specific investigations i.e., barium esophagram, esophago-gastroduodenoscopy, esophageal manometry and 24 hour ambulatory pH monitoring of the esophagus. All patients underwent laparoscopic Nissen Fundoplication. Patients were evaluated at three months after surgery with symptom scoring questionnaire.

Results: Mean age of patients in our study was 38 years and most common symptoms were heartburn and regurgitation. Four patients (11%) developed complications. The conversion rate to laparotomy was 2.7% (1 patient). Average symptom scores decreased from 10/18 to 0/18 after fundoplication (<0.0001) and all the eight patients who underwent postoperative endoscopy had normal results.

Conclusions: Laparoscopic Nissen’s fundoplication is a safe and effective procedure for GERD, having an acceptable hospital stay with consistently improved short term symptomatic and endoscopic results.


Gastro-oesophageal reflux, Laparoscopy, Nissen fundoplication

Full Text:



Vakil N, van Zanten SV, Kahrilas P. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-20.

Pope CE. Acid reflux disorders. N Engl J Med. 1995;331:656-60.

Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med. 1997;336:924-32.

Mittal RK. The crural diaphragm, an external lower esophageal sphincter: a definitive study. Gastroenterol. 1993;105:1565-7.

Page AJ, Blackshaw LA. An in vitro study of the properties of vagal afferent fibers innervating the ferret esophagus and stomach. J Physiol. 1998;512(Pt 3):907-16.

Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterol. 1995;109:601-10.

Trudgill NJ, Riley SA. Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol. 2001;96:2569-74.

Bredenoord AJ, Hemmink GJ, Smout AJ. Relationship between gastroesophageal reflux pattern and severity of mucosal damage. Neurogastroenterol Motil. 2009;21:807-12.

Jones MP, Sloan SS, Rabine JC. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol. 2001;96;1711-7.

Jones MP, Sloan SS, Jovanovic B. Impaired egress rather than increased access: an important independent predictor of erosive esophagitis. Neurogastroenterol Motil. 2002;14:625-31.

Kahrilas PJ. Supraesophageal complications of reflux disease and hiatal hernia. Am J Med. 2001;111:51-5.

Hetzel DJ, Dent J, Reed WD. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterol. 1988;95:903.

Stein JH, Hoeft S, DeMeester TR. Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg. 1993;105(1):107-111.

Baker ME, Einstein DM., Herts BR. Gastroesophageal reflux disease: integrating the barium esophagram before and after antireflux surgery. Radiol. 2007;243:329-39.

El-serag HB. Epidemiology of non-erosive reflux disease. Digestion. 2008;78(suppl 1):6-10.

Gyawali CP. High resolution manometry: the Ray Clouse legacy. Neurogastroenterol Motil. 2012;24:2-4.

Hirano I, Zhang Q, Pandolfino JE. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2005;3:1083-8.

Fischer JE. Fischer's mastery of surgery. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012.

Ness-Jensen E, Lindam A, Lagergren J. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012;61:1390-7.

Li YM, Du J, Zhang H. Epidemiological investigation in outpatients with symptomatic gastroesophageal reflux from the Department of Medicine in Zhejiang Province, east China. J Gastroenterol Hepatol. 2008;23:283-9.

Wong BC. and Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398-407.

Yamagishi H, Koike T, Ohara S. Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World J Gastroenterol. 2008;14:1358-64.

Locke GR, Talley NJ, Fett SL. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterol. 1997;112:1448-56.

Nouraie M, Razjouyan H, Assady M. Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey. Arch Iran Med. 2007;10:289-94.

Nocon M, Labenz J, and Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux: a population-based study. Aliment Pharmacol Ther. 2006;23:169-74.

Gotley DC, Smithers BM, Rhodes M. Laparoscopic Nissen fundoplication - 200 consecutive cases. Gut. 1996;38:487-91.

Peters JH, DeMeester TR, Crookes P. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with typical' symptoms. Ann Surg. 1998;228(1):40-50.

Dunnington GL and DeMeester TR. Outcome effect of adherence to operative principles of Nissen fundoplication by multiple surgeons. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Am J Surg. 1993;166:654-7.